Loading...
Loading...
OM| Name | Value |
|---|---|
| Revenues | 30.4M |
| Cost of Revenue | 23.2M |
| Gross Profit | 7.2M |
| Operating Expense | 52.6M |
| Operating I/L | -45.5M |
| Other Income/Expense | -0.6M |
| Interest Income | 2.6M |
| Pretax | -46.1M |
| Income Tax Expense | 0.1M |
| Net Income/Loss | -46.2M |
Outset Medical, Inc. develops the Tablo Hemodialysis System, a compact console that integrates water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The system is the primary source of revenue for the company, providing a comprehensive solution for hemodialysis. Outset Medical, Inc. focuses on the development and commercialization of its innovative hemodialysis system to generate profits.
